Adiponectin as a biomarker of clinical manifestation of metabolic syndrome

Endocrine Regulations

Volumn 40, Issue 1, 2006, Pages 15-19

  Tajtákova, Mária ^a,b   Petrášová, Darina ^a   Petrovičová, Jozefína ^a   Pytliak, Marek ^a   Semanová, Zuzana ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b Med Faculty of Safarik University   (Slovakia)

Author keywords

Adiponectin; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; INSULIN;

ARTICLE; BODY MASS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; ADULT; ANALYSIS OF VARIANCE; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; PHYSIOLOGY;

ADIPONECTIN; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY;

EID: 33749171254     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. BACHA F, SAAD R, GUNGOR N et al: Adiponectin in youth. Diabetes Care 27, 547-553, 2004
2. BAYS HE, ABATE N, CHANDALIA M: Adiposopathy: Sick fatty causes high blood sugar, high blood pressure, and dyslipidemia. Future Cardiology 1, 39-59, 2005
3. BETLOWSKI J: Adiponectin and resistin- new hormones of white adipose tissue. Med Sci Monit 2, 55-61, 2003
4. BRAKENHIELM E,VEITONMÄKI N, CAO R et al: Adiponectin- induced antiangiogenesis and antitumor activity involve caspasemediated endothelial cell apoptosis. PNAS 101, 1476-1481, 2004
5. DUNTAS LH, POPOVICV, PANOTOPOULOS G: Adiponectin: novelties in metabolism and hormonal regulation. Nutr Neurosci 7, 195-200, 2004
6. FERNANDEZ-REAL JM, CASTRO A, VAZQUEZ G et al: Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 27, 739-745, 2004
7. GIL-CAMPOS M, CANETE RR, GIL S: Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23, 963-974, 2004
8. GOLDSTEIN BJ, SCALIA R: Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89, 2563-2568, 2004
9. HATTORI S, HATTORI Y, KASAI K: Hypoadiponectinemia is caused by chronic blocades of nitric oxide synhesis in rats. Metabolism. 54, 482-487, 2005
10. KAWANO T, SAITO T, YASU T et al: Close association of hypoadiponectinemia with arteriosclerosis and ischemic heart disease. Metabolism 54, 653-656, 2004
11. KOBAYASHI K, INOGUCHI T, SONODA N et al: Adiponectin inhibits the binding of low-density lipoprotein to biglycan a vascular proteoglycan. Biochem Biophys Res Commun 335, 66-70, 2005
12. KUO-CHIN HUANG, BEE-HORNG LUE, RUOH-FANG YEN et al: Plasma Adiponectin Levels and Metabolic Factors in Nondiabetic Adolescents. Obesity Res 12, 119-124, 2004
13. LEE Y,H, PRATLEY RE: The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5, 70-75, 2005
14. LIHN AS, PEDERSEN SB, RICHELSEN B: Adiponectin: Action, regulation and association to insulin sensitivity. Obes Rev 6, 13-21, 2005
15. MAAHS DM, OGDEN LG, KINNEY, G L et al: Low plasma adiponectin levels predict progression of coronary artery classification. Circulation 111, 747-753, 2005
16. MATUSAZAWA Y: Adiponectin: Identificatitoin, physiology and clinical relevance in matabolic and vascular disease. Atherosclerosis Suppl 6, 7-14, 2004
17. MOHAN V, DEEPA R, PRADEEPA R et al: Association of low adiponectin levels with the metabolic syndrome- the Chennai Urban Rural Epidemiology Study. Metabolism 54, 476-481, 2005
18. MOLLER DE, KAUFMAN KD: Metabolic syndrome: A clinical and molecular perspective. Ann Rev Med 56, 45-62, 2005
19. PALOMER X, PEREZ A, BLANCO-VACA F: Adiponectin : a new link between obesity, insulin resistance and cardiovascular disease. Med Clin 124, 388-395, 2005
20. RADIKOVA Z: Assessment of insulin sensitivity/resistance in epidemiological studies. Endocrine Regulations 37, 188-194, 2003
21. RYO M, NAKAMURA T, KIHARA S et al: Adiponectin as a biomarker of the metabolic syndrome. Circ J 68, 975-981, 2004
22. SCHULTZE MB, SHAI I, RIMM EB et al: Adiponectin and Future Coronary Heart Disease Events Among Men With Typ 2 Diabetes. Diabetes 54, 534-539, 2005.
23. SONNENBERG GE, KRAKOWER GR, KISSEBAH AH: A novel pathway to the manifestation of metabolic syndrome. Obes Res. 12, 180-186, 2004.
24. TRUJILLO ME, SCHERER PE: Adiponectin- journey from an adipocyty secretory protein to biomarker of the metabolic syndrome. J Intern Med 257, 167-175, 2005